FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1837697010> ?p ?o ?g. }

• W1837697010 endingPage "9487" @default.
• W1837697010 startingPage "9476" @default.
• W1837697010 abstract "// Sébastien Tabariès 1, 2 , Matthew G. Annis 1, 2 , Brian E. Hsu 1, 2 , Christine E. Tam 1, 2 , Paul Savage 1, 2 , Morag Park 1, 2, 3, 4 , Peter M. Siegel 1, 2, 3 1 Goodman Cancer Research Centre, McGill University, Montréal, Québec, Canada, H3A 1A3 2 Department of Medicine, McGill University, Montréal, Québec, Canada, H3A 1A3 3 Department of Biochemistry, McGill University, Montréal, Québec, Canada, H3A 1A3 4 Department of Oncology, McGill University, Montréal, Québec, Canada, H3A 1A3 Correspondence to: Peter M. Siegel, e-mail: peter.siegel@mcgill.ca Keywords: breast cancer, liver metastasis, claudins, Src family kinase, Lyn Received: January 26, 2015      Accepted: January 31, 2015      Published: March 25, 2015 ABSTRACT Claudin-2 enhances breast cancer liver metastasis and promotes the development of colorectal cancers. The objective of our current study is to define the regulatory mechanisms controlling Claudin-2 expression in breast cancer cells. We evaluated the effect of several Src Family Kinase (SFK) inhibitors or knockdown of individual SFK members on Claudin-2 expression in breast cancer cells. We also assessed the potential effects of pan-SFK and SFK-selective inhibitors on the formation of breast cancer liver metastases. This study reveals that pan inhibition of SFK signaling pathways significantly elevated Claudin-2 expression levels in breast cancer cells. In addition, our data demonstrate that pan-SFK inhibitors can enhance breast cancer metastasis to the liver. Knockdown of individual SFK members reveals that loss of Yes or Fyn induces Claudin-2 expression; whereas, diminished Lyn levels impairs Claudin-2 expression in breast cancer cells. The Lyn-selective kinase inhibitor, Bafetinib (INNO-406), acts to reduce Claudin-2 expression and suppress breast cancer liver metastasis. Our findings may have major clinical implications and advise against the treatment of breast cancer patients with broad-acting SFK inhibitors and support the use of Lyn-specific inhibitors." @default.
• W1837697010 created "2016-06-24" @default.
• W1837697010 creator A5004290985 @default.
• W1837697010 creator A5019330087 @default.
• W1837697010 creator A5032728146 @default.
• W1837697010 creator A5043543722 @default.
• W1837697010 creator A5083606690 @default.
• W1837697010 creator A5085330220 @default.
• W1837697010 creator A5088293962 @default.
• W1837697010 date "2015-03-25" @default.
• W1837697010 modified "2023-10-01" @default.
• W1837697010 title "Lyn modulates Claudin-2 expression and is a therapeutic target for breast cancer liver metastasis" @default.
• W1837697010 cites W1574807134 @default.
• W1837697010 cites W1988212011 @default.
• W1837697010 cites W1988336108 @default.
• W1837697010 cites W1991657448 @default.
• W1837697010 cites W2000596607 @default.
• W1837697010 cites W2002697796 @default.
• W1837697010 cites W2020528737 @default.
• W1837697010 cites W2022690457 @default.
• W1837697010 cites W2023755204 @default.
• W1837697010 cites W2025397617 @default.
• W1837697010 cites W2026279585 @default.
• W1837697010 cites W2026700628 @default.
• W1837697010 cites W2030070767 @default.
• W1837697010 cites W2032716405 @default.
• W1837697010 cites W2034428193 @default.
• W1837697010 cites W2046822015 @default.
• W1837697010 cites W2055717436 @default.
• W1837697010 cites W2063747615 @default.
• W1837697010 cites W2067052531 @default.
• W1837697010 cites W2067620712 @default.
• W1837697010 cites W2069180517 @default.
• W1837697010 cites W2071437006 @default.
• W1837697010 cites W2087529099 @default.
• W1837697010 cites W2097208900 @default.
• W1837697010 cites W2100451270 @default.
• W1837697010 cites W2100772783 @default.
• W1837697010 cites W2105675816 @default.
• W1837697010 cites W2109462974 @default.
• W1837697010 cites W2112168902 @default.
• W1837697010 cites W2116701980 @default.
• W1837697010 cites W2120949833 @default.
• W1837697010 cites W2121390608 @default.
• W1837697010 cites W2136489225 @default.
• W1837697010 cites W2136929338 @default.
• W1837697010 cites W2136984184 @default.
• W1837697010 cites W2142739240 @default.
• W1837697010 cites W2144380085 @default.
• W1837697010 cites W2146127468 @default.
• W1837697010 cites W2156902552 @default.
• W1837697010 cites W2159664830 @default.
• W1837697010 cites W2159816664 @default.
• W1837697010 cites W2170234615 @default.
• W1837697010 cites W2342671164 @default.
• W1837697010 cites W2417450638 @default.
• W1837697010 cites W2418560940 @default.
• W1837697010 doi "https://doi.org/10.18632/oncotarget.3269" @default.
• W1837697010 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4496232" @default.
• W1837697010 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25823815" @default.
• W1837697010 hasPublicationYear "2015" @default.
• W1837697010 type Work @default.
• W1837697010 sameAs 1837697010 @default.
• W1837697010 citedByCount "44" @default.
• W1837697010 countsByYear W18376970102015 @default.
• W1837697010 countsByYear W18376970102016 @default.
• W1837697010 countsByYear W18376970102017 @default.
• W1837697010 countsByYear W18376970102018 @default.
• W1837697010 countsByYear W18376970102019 @default.
• W1837697010 countsByYear W18376970102020 @default.
• W1837697010 countsByYear W18376970102021 @default.
• W1837697010 countsByYear W18376970102022 @default.
• W1837697010 countsByYear W18376970102023 @default.
• W1837697010 crossrefType "journal-article" @default.
• W1837697010 hasAuthorship W1837697010A5004290985 @default.
• W1837697010 hasAuthorship W1837697010A5019330087 @default.
• W1837697010 hasAuthorship W1837697010A5032728146 @default.
• W1837697010 hasAuthorship W1837697010A5043543722 @default.
• W1837697010 hasAuthorship W1837697010A5083606690 @default.
• W1837697010 hasAuthorship W1837697010A5085330220 @default.
• W1837697010 hasAuthorship W1837697010A5088293962 @default.
• W1837697010 hasBestOaLocation W18376970101 @default.
• W1837697010 hasConcept C108636557 @default.
• W1837697010 hasConcept C121608353 @default.
• W1837697010 hasConcept C126322002 @default.
• W1837697010 hasConcept C170493617 @default.
• W1837697010 hasConcept C173396325 @default.
• W1837697010 hasConcept C175818844 @default.
• W1837697010 hasConcept C190283241 @default.
• W1837697010 hasConcept C2779013556 @default.
• W1837697010 hasConcept C502942594 @default.
• W1837697010 hasConcept C530470458 @default.
• W1837697010 hasConcept C55493867 @default.
• W1837697010 hasConcept C71924100 @default.
• W1837697010 hasConcept C86803240 @default.
• W1837697010 hasConceptScore W1837697010C108636557 @default.
• W1837697010 hasConceptScore W1837697010C121608353 @default.
• W1837697010 hasConceptScore W1837697010C126322002 @default.

• next